Wegovy is produced by pharmaceutical company Novo Nordisk. Weight-loss drug makers are directly targeting employers in a ...

Old Town Med Spa is among those being accused of using false advertising and deceptive marketing practices to sell ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

Verge Genomics announced that Eli Lilly (LLY) has opted to pursue the development of therapeutics against two validated drug targets for ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY) and Pfizer ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Eli Lilly CEO Dave Ricks told investors during a call following the announcement that there wasn't a "demand problem here," but revealed that the company would start marketing Zepbound specifically ...

Eli Lilly CEO Dave Ricks told investors during a call following the announcement that there wasn't a "demand problem here," but revealed that the company would start marketing Zepbound ...